Phase 3 Alopecia Areata Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The trial doctor has reviewed your health history and screening results and considers you to be in good health.
- You have been diagnosed with severe alopecia areata (a condition causing significant hair loss) with at least 25% of your scalp hair lost, confirmed at both your screening and baseline appointments.
- Your current episode of alopecia areata started less than 8 years ago.
Who may not be able to join:
- You have been diagnosed with a diffuse type of alopecia areata (where hair loss is spread evenly across the scalp rather than in patches).
- You have another type of hair loss condition — such as male or female pattern baldness (at a certain level of severity), traction alopecia, or several other specific scalp conditions — that could affect how the trial results are measured (confirm with trial site if unsure which conditions apply to you).
- You have another inflammatory condition affecting your scalp, eyebrows, or eyelashes — such as seborrheic dermatitis, scalp psoriasis, eczema, or a fungal scalp infection — that could affect how the trial results are measured.
- You have had an active infection requiring treatment through a drip (IV) within the last 30 days, or by mouth or injection within the last 14 days before your baseline appointment.
- You have a long-term recurring infection or an ongoing viral infection that the trial doctor believes makes it unsafe for you to participate.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: ABBVIE INC., AbbVie
Phone: 844-663-3742
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Participants with the Achievement of Severity of Alopecia Tool (SALT) Score <= 10; Number of Participants with Adverse Events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.